Mr. John LeDonne plays a key role in the expansion of Innoteq, Inc’s technical knowledge base. His primary function is to direct research into innovative products and processes. His research directs the implementation of new therapeutic agents in novel dosage forms. He oversees new product ideation, formulation development and analytical development activities. These projects include prescription and over the counter drugs, medical devices, dietary supplements, cosmetics and food applications.
 
Mr. LeDonne received his Bachelor’s Degree in Physics and Chemistry from Rutgers University in New Jersey. Prior to joining Innoteq, he held research positions at Lohmann Therapy and Baxter Healthcare. At Lohmann Therapy Systems, Mr. LeDonne worked in the Research and Development Department and specialized in Oral Thin Films technology for the delivery of therapeutic agents. His other research projects included specialty intermediates for trans-dermal delivery systems and medical devices. At Baxter Healthcare, Mr. LeDonne worked for the Anesthesia and Critical Care Unit in the Formulation Department. His work included parenteral dosage forms as well as lyophilization and emulsion technology.


At HBA, he is speaking in the session T-05: Novel Technologies to Increase Efficacy and Delivery of High Performance Nutraceuticals.